Increased membrane lipid peroxidation and decreased Na+/K+-ATPase activity in erythrocytes of patients with stable coronary artery disease

Coronary Artery Disease

Volumn 26, Issue 3, 2015, Pages 239-244

  Namazi, Gholamreza ^a   Jamshidi Rad, Sabieh ^b   Attar, Ahmad Movahedian ^a   Sarrafzadegan, Nizal ^b   Sadeghi, Masoumeh ^c   Naderi, Gholamali ^b   Pourfarzam, Morteza ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

coronary artery disease; erythrocyte; lipid peroxidation; Na + K + ATPase; total antioxidant status

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC ACID DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; BIOLOGICAL MARKER; MEMBRANE LIPID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE GHOST; ERYTHROCYTE MEMBRANE; FEMALE; FLUOROMETRY; HUMAN; HUMAN CELL; HYPERTENSION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; BLOOD; CASE CONTROL STUDY; CORONARY ANGIOGRAPHY; DOWN REGULATION; ENZYMOLOGY; IRAN; METABOLISM; MIDDLE AGED; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; SPECTROFLUOROMETRY;

ANTIOXIDANTS; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOWN-REGULATION; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; IRAN; LIPID PEROXIDATION; MALE; MEMBRANE LIPIDS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPECTROMETRY, FLUORESCENCE;

EID: 84928280231     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000196     Document Type: Article

References (33)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-1695.
2. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84:1381-1478.
3. Lakshmi SV, Naushad SM, Reddy CA, Saumya K, Rao DS, Kotamraju S, Kutala VK. Oxidative stress in coronary artery disease: epigenetic perspective. Mol Cell Biochem 2013; 374:203-211.
4. Vichova T, Motovska Z. Oxidative stress: predictive marker for coronary artery disease. Exp Clin Cardiol 2013; 18:e88-e91.
5. Weinbrenner T, Cladellas M, Isabel Covas M, Fitó M, Tomás M, Sentí M, et al. High oxidative stress in patients with stable coronary heart disease. Atherosclerosis 2003; 168:99-106.
6. Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984; 1:1396-1397.
7. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45:337-351.
8. Bryszewska M, Zavodnik IB, Niekurzak A, Szosland K. Oxidative processes in red blood cells from normal and diabetic individuals. Biochem Mol Biol Int 1995; 37:345-354.
9. Arbos KA, Claro LM, Borges L, Santos CA, Weffort-Santos AM. Human erythrocytes as a system for evaluating the antioxidant capacity of vegetable extracts. Nutr Res 2008; 28:457-463.
10. Akku I, Salam NI, Calayan O, Vural H, Kalak S, Saglam M. Investigation of erythrocyte membrane lipid peroxidation and antioxidant defense systems of patients with coronary artery disease (CAD) documented by angiography. Clin Chim Acta 1996; 244:173-180.
11. Pytel E, Olszewska-Banaszczyk M, Koter-Michalak M, Broncel M. Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients. Biochem Cell Biol 2013; 91:315-318.
12. Baba A, Yoshikawa T, Mitamura H, Ogawa S. Erythrocyte Na+, K+-ATPase activity in patients with congestive heart failure. Int J Cardiol 1999; 69:117-125.
13. Lu G, Ouyang S, Pei Z. Changes of erythrocyte membrane ATPase activities and plasma lipids in patients with coronary heart disease. Hunan Yi Ke Da Xue Xue Bao 1999; 24:68-70.
14. Emami Razavi A, Pourfarzam M, Ani M, Naderi GA. The associations between high-density lipoprotein mean particle size and its fatty acid composition. Biomark Med 2013; 7:235-245.
15. Siavash M, Sadeghi M, Salarifar F, Amini M, Shojaee-Moradie F. Comparison of body mass index and waist/height ratio in predicting definite coronary artery disease. Ann Nutr Metab 2008; 53:162-166.
16. Chauhan VP, Tsiouris JA, Chauhan A, Sheikh AM, Brown WT, Vaughan M. Increased oxidative stress and decreased activities of Ca(2 + )/Mg(2 + )-ATPase and Na(+ )/K(+ )-ATPase in the red blood cells of the hibernating black bear. Life Sci 2002; 71:153-161.
17. DeLuise M, Flier JS. Functionally abnormal Na+-K+ pump in erythrocytes of a morbidly obese patient. J Clin Invest 1982; 69:38-44.
18. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87:206-210.
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351-358.
20. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66:375-400.
21. Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 2007; 40:181-187.
22. Serdar Z, Aslan K, Dirican M, Sarandöl E, Yeilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 2006; 39:794-803.
23. Karmansky I, Shnaider H, Palant A, Gruener N. Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease. Clin Biochem 1996; 29:573-579.
24. Mutlu-Türkolu U, Akalin Z, Ilhan E, Yilmaz E, Bilge A, Nianci Y, Uysal M. Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease. Clin Biochem 2005; 38:1059-1065.
25. Rao V, Kiran R. Evaluation of correlation between oxidative stress and abnormal lipid profile in coronary artery disease. J Cardiovasc Dis Res 2011; 2:57-60.
26. Sakuma N, Hibino T, Sato T, Ohte N, Akita S, Tamai N, et al. Levels of thiobarbituric acid-reactive substance in plasma from coronary artery disease patients. Clin Biochem 1997; 30:505-507.
27. Dogru-Abbasoglu S, Kanbagli O, Bulur H, Babalik E, Oztürk S, Aykaç-Toker G, Uysal M. Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis. Clin Biochem 1999; 32:671-672.
28. Halevy D, Thiery J, Nagel D, Arnold S, Erdmann E, Höfling B, et al. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. Arterioscler Thromb Vasc Biol 1997; 17:1432-1437.
29. Padmavathi P, Reddy VD, Kavitha G, Paramahamsa M, Varadacharyulu N. Chronic cigarette smoking alters erythrocyte membrane lipid composition and properties in male human volunteers. Nitric Oxide 2010; 23:181-186.
30. Muriel P, Castañeda G, Ortega M, Noël F. Insights into the mechanism of erythrocyte Na+/K+-ATPase inhibition by nitric oxide and peroxynitrite anion. J Appl Toxicol 2003; 23:275-278.
31. Maturu P, Vaddi DR, Pannuru P, Nallanchakravarthula V. Alterations in erythrocyte membrane fluidity and Na+/K+-ATPase activity in chronic alcoholics. Mol Cell Biochem 2010; 339:35-42.
32. Markovic S, Dordevic J, Majkic-Singh N, Vasiljevic Z, Petrovic M, Glavinic L, et al. The importance of antioxidant enzyme and total antioxidant status of patients with acute myocardial infarction on thrombolytic therapy. Clin Lab 2000; 46:495-499.
33. Fazendas P, Joaõ IF, Llobet S, Matias F, Pereira H, Oliveira LM, Carrageta M. Plasma total anti-oxidant status in young survivors of myocardial infarction. Rev Port Cardiol 2000; 19:463-467.